Trademarkia Logo

Canada

C$
AUREGEN BIOTHERAPEUTICS
REGISTERED

on 8 Aug 2019

Last Applicant/ Owned by

AUREGEN BIOTHERAPEUTICS SA

Avenue Guiseppe-Motta 31-371202 Geneva

CH

Serial Number

1824302 filed on 23rd Feb 2017

Registration Number

TMA1047916 registered on 8th Aug 2019

Registration expiry Date

8th Aug 2029

Correspondent Address

LAVERY, DE BILLY, LLP

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

CA

H3B4M4

AUREGEN BIOTHERAPEUTICS

Trademark usage description

stem cells for research purposes, stem cells for scientific purposes, stem cells for research and scientific purposes, hydrogel polymer coatings, lact Read More

Classification Information


Class [001]
Stem cells for research purposes, stem cells for scientific purposes, stem cells for research and scientific purposes, hydrogel polymer coatings, lactic acid polymers, aqueous linear polymer gels, photo curable compositions comprising polymers, chemicals for use in polymerisations, engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research, biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue, chemical products for the purification of proteins for in-vitro use, all the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatments


Classification kind code

10

Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of bone fractures, pharmaceutical preparations for the treatment of diseases, disorders and infections affecting bone, skin and cartilage, pharmaceutical preparations for the treatment of the musculoskeletal system, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries and cartilage deformation, preparations based on cellulose nano-fibrils for use in the 3d bio-printing of tissues and organs, tissue-regenerative pharmaceutical preparations, biological implants for skin and cartilage, biological tissue for implantation, autologous cells for medical use, human allograft tissue, implants of living tissues for guided tissue regeneration, implantable materials namely cytocompatible polymers for use in guided tissue regeneration, skin grafts, surgical implants comprised of living tissues, surgical implants grown from stem cells [living tissues], transdermal patches for use to create skin for prosthetic limbs and for skin grafts, living tissues for transplants, antibodies for use to create skin for prosthetic limbs and for skin grafts, stem cells for medical purposes, engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes, biological molecules, namely peptides, proteins, lipids and carbohydrates, to assist in the development of tissue, hemostatic gel matrix preparations for treating wound, natural biomaterials, namely bone-derived graft materials, for augmentation of bone, blood and tissue for medical purposes, processed human donor skin for the replacement of soft tissue, pharmaceutical preparations for gene therapy, cell therapy, tissue regeneration, tissue repair, tissue treatment, whether relating to human and animal tissue, pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation, biomaterials for bone filling, biomaterials for filling cartilage, stem cells for medical us, surgical cloths for wound protection, surgical implants grown from stem cells, biological tissue cultures for medical use, all the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatments


Classification kind code

10

Class [007]
Three-dimensional [3D] printers (3D printers); three-dimensional [3D] bioprinters (3D bioprinters); machines, namely, three dimensional (3D) bioprinter for the manufacturing of living tissues; machines, namely, three dimensional (3D) bioprinter for the printing of living tissues; cartridges for containing printing material; cartridges for containing bioprinting material; printing cartridges for containing biomaterial; printing cartridges for containing bioink


Classification kind code

10

Class [009]
Laboratory incubators for fabrication of three-dimensional tissues and organs, biochips sensors for the production of three-dimensional tissues and organs, bioreactor for cell culturin, bioreactors for laboratory use, bioreactors for research use, cell culture apparatus for laboratory use, namely, cell culture dishes, tissue culture flasks, image scanners, 3D scanners for laboratory use and laboratory instruments for use in research on biomaterials adapted and used for printing three-dimensional objects for the creation of prosthetic limbs and grafts, LED microscopes, print heads for inkjet printers, scientific research and laboratory apparatus namely laboratory incubators, laboratory robots and instruments for research on biomaterials adapted and used for printing three-dimensional objects for the creation of prosthetic limbs and grafts in the field of cytology, laboratory apparatus namely laboratory incubators, laboratory robots and instruments for research on biomaterials adapted and used for printing three-dimensional objects for the creation of prosthetic limbs and grafts for use in biopharmaceutical discovery and development, all the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatments


Classification kind code

10

Class [010]
Surgical, medical, dental apparatus and instruments namely phototherapeutic apparatus for medical purposes, medical x-ray apparatus, medical and surgical knives and cutters for cutting human and animal tissue and organs, medical instruments for cutting tissue, orthopedic articles namely orthopedic braces, orthopedic belts, orthopedic corsets, orthopedic bone implants, orthopedic bone screws, artificial limbs, artificial implants namely intravascular implant medical devices made of artificial material, medical, surgical and orthopedic implants made of artificial materials, osseous implants made of artificial materials, spinal implants made of artificial materials, cartilage implants made of artificial materials, bone substitutes for surgical use, fluid injectors for medical purposes, trocars, artificial tissue replacement for restoring, maintaining and improving the function of diseased and damaged human and animal tissue (tissue engineering), synthetic implants and transplants and modified implants and transplants, tissue, cells and molecules for replacing and for supporting the function of missing and damaged body parts, synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement, modified implants and transplants with endogenous material, tissue, cells and molecules for replacing and for supporting the function of missing and damaged body parts, all the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatments


Classification kind code

10

Class [040]
3D printing services; renting of 3D printers; creation of customised three-dimensional shaped parts using rapid prototyping equipment; 3D bioprinting; bioprinting


Classification kind code

10

Class [042]
Technical research in the fields of biomimetics, biomaterials, material adaptation, 3d bioprinting and tissue engineering, research and development of medical devices, research in the field of nanotechnology and nanomaterials, synthetic biology research, robotics research, bioengineering research, nanotherapeutics research, 3d bioprinting research, tissue engineering research, scientific and medical research and development in the field of bio-printing, research and development of 3D technology and processes, development of rapid prototyping equipment, technical consultancy relating to rapid prototyping, scientific research consulting in the fields of three-dimensional printing, scientific services relating to the isolation and cultivation of human tissues and cells, scientific and medical research and development in the field of tissue manufacturing, development and culture of artificial tissues and cells (tissue engineering), tissue engineering services, industrial analysis and research services in the field of tissue engineering, research in the fields of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals, research and testing services in the fields of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals, research and development of new products for others in the fields of regenerative biotherapies, genomics, biotechnology, chemicals and pharmaceuticals, design and development of computer hardware and software, all the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatments


Classification kind code

10

Class [044]
Medical services, namely in the field of gene and cellular immunotherapies and transplantation, monitoring and reporting services, medical treatment services, consulting services in the fields of medical treatment and medicines, human cell and tissue banking services, collection and preservation of human blood and cells for medical us, all the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatments


Classification kind code

10

Mark Details


Serial Number

1824302

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 14th Mar 2019
Approved
Submitted for opposition 27
on 22nd Jan 2019
Approval Notice Sent
Submitted for opposition 67
on 5th Sept 2018
Agent Name Changed
Submitted for opposition 68
on 5th Sept 2018
Rep for Service Name Changed
Submitted for opposition 15
on 16th Aug 2018
Correspondence Created
Submitted for opposition 22
on 25th Jan 2018
Search Recorded
Submitted for opposition 20
on 25th Jan 2018
Examiner's First Report
Submitted for opposition 31
on 27th Feb 2017
Formalized
Submitted for opposition 1
on 24th Feb 2017
Created
Submitted for opposition 30
on 23rd Feb 2017
Filed